Market Development For Genetically Modified Foods

The investment climate for firms producing genetically modified (GM) agricultural products has recently experienced considerable change, with the occurrence of remarkably high rate of farmer acceptance, but considerable consumer resistance. The present system that involves firms developing biotech products, farmers producing the products, food and related agribusiness industrial firms, and consumers of food, is very volatile. This however will soon be affected by changes in reulatory, trade and food safety regimes.This book addresses these key issues and is based on papers presented at the fourth meeting of The International Consortium on Agricultural Biotechnology Research (ICABR), on Economics of Agricultural Biotechnology, held at Ravello, Italy, in August 2000. Organized in four parts, this volume focuses on:Consumer reactions to GM food informationRegulatory issuesFarmer acceptance of biotech productsChanges in industrial organization in life science and food sectors

This title gives readers a balanced look at the issue of genetically modified foods and the surrounding arguments. Readers will learn about the history of genetically modified foods, as well as political aspects of the debate and concerns regarding expense, the environment, culture, and religion. Additionally, the use of genetically modified foods to help food markets in third-world countries is explained. Also covered are business practices, including biotechnology and patents. Color photos and informative sidebars accompany easy-to-follow text. Features include a timeline, facts, additional resources, web sites, a glossary, a bibliography, and an index. Essential Viewpoints is a series in Essential Library, an imprint of ABDO Publishing Company.

The transatlantic dispute over genetically modified organisms (GMOs) has brought into conflict the United States and the European Union, two long-time allies and economically interdependent democracies with a long record of successful cooperation. Yet the dispute - pitting a largely acceptant US against an EU deeply suspicious of GMOs - has developed into one of the most bitter and intractable transatlantic and global conflicts, resisting efforts at negotiated resolution and resulting in a bitterly contested legal battle before the World Trade Organization. Professors Pollack and Shaffer investigate the obstacles to reconciling regulatory differences among nations through international cooperation, using the lens of the GMO dispute. The book addresses the dynamic interactions of domestic law and politics, transnational networks, international regimes, and global markets, through a theoretically grounded and empirically comprehensive analysis of the governance of GM foods and crops. They demonstrate that the deeply politicized, entrenched and path-dependent nature of the regulation of GMOs in the US and the EU has fundamentally shaped negotiations and decision-making at the international level, limiting the prospects for deliberation and providing incentives for both sides to engage in hard bargaining and to "shop" for favorable international forums. They then assess the impacts, and the limits, of international pressures on domestic US and European law, politics and business practice, which have remained strikingly resistant to change. International cooperation in areas like GMO regulation, the authors conclude, must overcome multiple obstacles, legal and political, domestic and international. Any effective response to this persistent dispute, they argue, must recognize both the obstacles to successful cooperation, and the options that remain for each side when cooperation fails.

Assists policymakers in evaluating the appropriate scientific methods for detecting unintended changes in food and assessing the potential for adverse health effects from genetically modified products. In this book, the committee recommended that greater scrutiny should be given to foods containing new compounds or unusual amounts of naturally occurring substances, regardless of the method used to create them. The book offers a framework to guide federal agencies in selecting the route of safety assessment. It identifies and recommends several pre- and post-market approaches to guide the assessment of unintended compositional changes that could result from genetically modified foods and research avenues to fill the knowledge gaps.

In Thwarting Consumer Choice, Gary E. Marchant, Guy A. Cardineau, and Thomas P. Redick contend that mandatory GM labeling laws actually harm consumers by pushing genetically modified foods off the market.

Genetically engineered (GE) crops were first introduced commercially in the 1990s. After two decades of production, some groups and individuals remain critical of the technology based on their concerns about possible adverse effects on human health, the environment, and ethical considerations. At the same time, others are concerned that the technology is not reaching its potential to improve human health and the environment because of stringent regulations and reduced public funding to develop products offering more benefits to society. While the debate about these and other questions related to the genetic engineering techniques of the first 20 years goes on, emerging genetic-engineering technologies are adding new complexities to the conversation. Genetically Engineered Crops builds on previous related Academies reports published between 1987 and 2010 by undertaking a retrospective examination of the purported positive and adverse effects of GE crops and to anticipate what emerging genetic-engineering technologies hold for the future. This report indicates where there are uncertainties about the economic, agronomic, health, safety, or other impacts of GE crops and food, and makes recommendations to fill gaps in safety assessments, increase regulatory clarity, and improve innovations in and access to GE technology.

This important collection prepared by Robert E. Evenson and Terri Raney - leading scholars in the field - focuses on one of the most controversial issues of our time - the genetic modification of agricultural produce. Whilst the US and Canada are supportive of GM crops, the European Union urges other countries to involve the 'precautionary principle' in regulatory policy. This comprehensive volume, which will appeal to scholars and practitioners alike, includes papers discussing this European Union-North American divide and possible resolutions of differences on this subject. Topics examined include: the technology; the industry; farmer adoption; consumer acceptance; economic impacts; the emergence of GM free markets and GM products for developing countries.

Fifteen years after the first genetically modified (GM) seeds and food, only four GM plants have achieved significant market positions: corn, cotton, rapeseed and soybeans. Most of the other new constructs have caused unsolved problems or are only at the project stage, demonstrating the complexity of the task facing biotech companies. Doubts are also emerging about the real economic and agronomic benefits of genetically modified organisms. Little is known about their potential for upsetting environmental biodiversity in an irreversible way. Worries about their impact on human health have not been dispelled but have increased with the evident incapacity of current international standards to ensure controls and enforcement. Reliable risk assessment models and methodologies have not yet been developed and cannot be expected soon: this makes it impossible to assess the nature (qualitative aspects) and extent (quantitative aspects) of the risks, and prevents estimates based on the risk/benefit ratio. In this situation it seems prudent to resort to the precautionary principle, defined in the Cartagena Protocol and incorporated in the Rio Declaration. The stakes are high and discussion needs to be brought to a level of scientific proof that leaves no room for ambiguity or alibis. Governments, companies and scientists must be called to respond to the specific questions raised by the vast scientific literature. There have been too many accusations of poor science and too many unproven claims and statements, symptomatic of conflicts of interest. It is time for fair debate with all sides on an equal footing.